Overview

Parse Biosciences focuses on advancing single-cell research by providing solutions that allow scientists to analyze individual cells with high precision. Their technology, known as "split-pool combinatorial barcoding," enables scalable single-cell analysis without the need for expensive custom instruments. The company offers an end-to-end solution that includes preparing cell or nuclei suspensions, sequencing, and data analysis, all supported by their proprietary software, Trailmaker. Unlike competitors, Parse Biosciences emphasizes accessibility and scalability in their products, making advanced single-cell analysis available to a wider range of researchers and institutions. Their goal is to push the boundaries of single-cell science and support researchers in pioneering new areas of inquiry.

💡 Want to apply to Parse Biosciences?

You have ways to get a Parse Biosciences referral from your network.

Get referrals →

Simplify's Take

What believers are saying

• Growing interest in spatial transcriptomics enhances Parse's single-cell sequencing offerings.
• AI integration in genomics presents opportunities for Parse's Trailmaker software.
• The rise of personalized medicine increases demand for Parse's precise cellular data solutions.

What critics are saying

• Emerging biotech startups offer similar single-cell sequencing solutions, increasing competition.
• Supply chain vulnerabilities could disrupt Parse's operations in the biotechnology sector.
• Rapid technological advancements may render Parse's current solutions obsolete without innovation.

What makes Parse Biosciences unique

• Parse Biosciences uses split-pool combinatorial barcoding for scalable single-cell analysis.
• Their technology eliminates the need for expensive microfluidic instruments in sequencing.
• Parse's solutions allow for fixed samples to be stored and analyzed together.

Help us improve and share your feedback! Did you find this helpful?

YesNo